CATALYST PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
官方登记数据
0位关注者
2002成立于
关于 CATALYST PHARMACEUTICALS, INC.
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially launched in January 2019.
Source: Wikipedia
行业Pharmaceutical Preparations
总部355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
成立2002
法律形式C Corporation
状态营业中
专利4 项专利
VAMOROLONE SOLID ORAL DOSAGE FORMSWO2026035689A1 · 2026
METHOD FOR TREATING BOTULINUM TOXIN POISONINGWO2023023463A1 · 2023
关键数据
法律信息
| 法定名称 | CATALYST PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1369568在 SEC EDGAR 上查看 ↗ |
| 行业代码(SIC) | 2834 |
| 注册地址 | 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面